Response to the Comment on "Active Surveillance Versus Immediate Surgery in Clinically Complete Responders After Neoadjuvant Chemoradiotherapy for Esophageal Cancer"

Affiliations

Comment

Berend J van der Wilk et al. Ann Surg. 2021.

. 2021 Dec 1;274(6):e697-e698.

doi: 10.1097/SLA.0000000000003861.

¹ Department of Surgery, Erasmus MC - University Medical Center, Rotterdam, The Netherlands.

No abstract available

Conflict of interest statement

The authors report no conflicts of interest.

Active Surveillance Versus Immediate Surgery in Clinically Complete Responders After Neoadjuvant Chemoradiotherapy for Esophageal Cancer: A Multicenter Propensity Matched Study.
van der Wilk BJ, Noordman BJ, Neijenhuis LKA, Nieboer D, Nieuwenhuijzen GAP, Sosef MN, van Berge Henegouwen MI, Lagarde SM, Spaander MCW, Valkema R, Biermann K, Wijnhoven BPL, van der Gaast A, van Lanschot JJB, Doukas M, Nikkessen S, Luyer M, Schoon EJ, Roef MJ, van Lijnschoten I, Oostenbrug LE, Riedl RG, Gisbertz SS, Krishnadath KK, Bennink RJ, Meijer SL; Collaborators:. van der Wilk BJ, et al. Ann Surg. 2021 Dec 1;274(6):1009-1016. doi: 10.1097/SLA.0000000000003636. Ann Surg. 2021. PMID: 31592898
Comment on "Active Surveillance Versus Immediate Surgery in Clinically Complete Responders After Neoadjuvant Chemoradiotherapy for Esophageal Cancer".
Molena D, Louie BE, Demeester SR. Molena D, et al. Ann Surg. 2021 Dec 1;274(6):e695-e696. doi: 10.1097/SLA.0000000000003858. Ann Surg. 2021. PMID: 32149823 No abstract available.

1. van der Wilk BJ, Noordman BJ, Neijenhuis LKA, et al. Active surveillance versus immediate surgery in clinically complete responders after neoadjuvant chemoradiotherapy for esophageal cancer: A multicenter propensity matched study [published online ahead of print, 2019 Oct 4]. Ann Surg 2019; doi:10.1097/SLA.0000000000003636. - DOI
1. Noordman BJ, Spaander MCW, Valkema R, et al. Detection of residual disease after neoadjuvant chemoradiotherapy for oesophageal cancer (preSANO): a prospective multicentre, diagnostic cohort study. Lancet Oncol 2018; 19:965–974.
1. Noordman BJ, Wijnhoven BPL, Lagarde SM, et al. Neoadjuvant chemoradiotherapy plus surgery versus active surveillance for oesophageal cancer: a stepped-wedge cluster randomised trial. BMC Cancer 2018; 18:142.
1. ClinicalTrials.gov Internet. Bethesda (MD): National Library of Medicine (US). 2000 Feb 29 -. Identifier NCT03937362, Pre-Surgery If Needed for Oesophageal Cancer (preSINO); 2019 May 3 cited 2020 Jan 13. Available at: https://ClinicalTrials.gov/show/NCT03937362
1. Shapiro J, van Lanschot JJB, Hulshof M, et al. Neoadjuvant chemoradiotherapy plus surgery versus surgery alone for oesophageal or junctional cancer (CROSS): long-term results of a randomised controlled trial. Lancet Oncol 2015; 16:1090–1098.